ChemPartner is a global life science CRO/CDMO with over 15 years of pharmaceutical research experience. We are proud to be involved with the 2020 Oxford Global R&D Series.
ChemPartner’s integrated service for antibody discovery helps clients go from target to candidate selection. We have a comprehensive biology capability for target validation. Our multiple, integrated platforms support reagent generation, assay development, and bioanalytical analysis. We offer hybridoma, phage display and B cell cloning platforms for antibody lead candidate generation supported by strong antibody engineering assets for candidate optimization. We continue to invest in new technologies such as Berkeley Light’s Beacon Optofluidics platform.
Our biologics CMC capabilities provide large-molecule CMC development and GMP manufacturing to support overall IND and NDA application requirements and beyond for clients. Our services cover stable cell line development, process development and GMP production from cell culture, purification, to aseptic filling and lyophilization at pilot-scale and commercial level.